Department of Health and Human Services, through National Institutes of Health, awarded Biosensics LLC of Newton, MA $5,174,076 under the SBIR program (Phase II), with work starting 2025-09-01 and running to 2029-08-31. It is one of 3 SBIR and STTR awards Biosensics LLC received in the last two years, $7,518,476 in all. Each figure links to the federal record.
The award
| Recipient | Biosensics LLC (Newton, MA) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | National Institutes of Health |
| Phase | Phase II |
| Amount obligated | $5,174,076 |
| Period of performance starts | 2025-09-01 |
| Period of performance ends | 2029-08-31 |
| Award number | UF1AG094587 (grant, CFDA 93.866) |
| Assistance listing | 93.866, Aging Research |
| Signed | 2025-08-28 |
| Recipient registry id (UEI) | C9MRZK4B7K39 |
Want the whole picture on Biosensics LLC?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biosensics LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biosensics LLC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
Digital health technologies for monitoring motor function in progressive supranuclear palsy and dementia with lewy bodies - project summary progressive supranuclear palsy (psp) is a severe and rapidly progressive frontot
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2025-08-28 | New | 000 | $5,174,076 |
Digital health technologies for monitoring motor function in progressive supranuclear palsy and dementia with lewy bodies - project summary progressive supranuclear palsy (psp) is a severe and rapidly progressive frontotemporal lobar degeneration (ftld) syndrome that lacks effective treatment and leads to a rapid onset of dementia, disability, and death. Dementia with lewy bodies (dlb) is the second most common type of neurodegenerative dementia after alzheimer’s disease. Both psp and dlb cause significant motor impairment, resulting in progressive loss of independence in activities of daily living, such as eating, dressing, and writing. There are no fda-approved treatments for ftld syndromes (including psp) or dlb. One of the key challenges in the development of new effective therapies for dlb syndromes is the lack of validated instruments and biomarkers to measure disease severity, disease progression, and the effect of therapeutic interventions. Since 2019, biosensics, massachusetts general hospital (mgh) and johns hopkins university (jhu) have partnered to develop a wearable-based remote monitoring solution for ftld syndromes. The solution uses pamsystm, a patented and validated pendant sensor for monitoring physical activity, posture, and walking parameters during activities of daily living. Through a direct Phase II SBIR award (R44AG080861) from the national institute on ...
From the federal award record.
Other SBIR and STTR awards to Biosensics LLC
| Starts | Agency | Program | Amount | Project |
|---|---|---|---|---|
| 2026-09-01 | Department of Health and Human Services | STTR Phase I | $314,362 | Digital assessment of motor skills in infants and young boys with duchenne muscular dystro (record) |
| 2025-09-01 | Department of Health and Human Services | SBIR Phase II | $2,030,038 | A wearable sensor platform for remote monitoring of motor impairment in huntingtons diseas (record) |
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Biosensics LLCLook up Biosensics LLC and see what is on record before you decide.
Get the free SnapshotWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.